First-in-Class Device for Facial Wrinkles Hits the Market

  • 📰 Medscape
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 55%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Evoke is the first FDA-cleared wearable, hands-free device that uses bipolar radiofrequency to target the lower third of the face and the submental area of the face. DermTwitter

DENVER – One expert's clinical experience suggests that Ellacor, a dermal microcoring device that became available in the United States in October 2022, is an effective treatment for facial wrinkles and tightening."It's early yet, but I have treated dozens of patients with this device, and they have been happy with the results,"

A brainchild of dermatologists and plastic surgeons at Massachusetts General Hospital, Boston, the first-in-class device isby the Food and Drug Administration for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. It features a proprietary needle design that makes a series of high throughput microexcisions in epidermal and dermal tissue, with minimal downtime and without using thermal energy.

The device features needle cartridges capable of excising up to 24,000 cores per treatment. According to data from Cytrellis, the manufacturer, the equivalent of about 2 inches of skin can be removed during the procedure, which typically takes fewer than 30 minutes to perform."There is no heat whatsoever," Avram said."In my experience, it especially helps with jawline definition, the lower medial cheek excess skin, and accordion lines in that area.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 386. in BE

Belgique Dernières Nouvelles, Belgique Actualités